Small Cap Taiwanese (TAIEX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Apr 24, 2024

Discover small cap Taiwanese Pharmaceuticals & Biotech companies that are on the TAIEX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

121 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6566

Chuang Yi Biotech
NT$5.200%-65.3%NT$176.5mn/aPB1.3xn/an/a

6848

RBC Bioscience
NT$16.052.6%-8.5%NT$208.3mn/aPS1.3xn/a7.0%

6661

Welgene BiotechLtd
NT$23.204.5%3.1%NT$540.7mn/aPS1.9xn/a0%

4170

Vectorite Biomedical
NT$15.10-0.7%n/aNT$660.9mn/aPS12.5xn/an/a

6864

Anti-Microbial Savior BioteQ
NT$27.808.2%-18.2%NT$695.0mn/an/an/an/a

6917

Andros PharmaceuticalsLtd
NT$21.60-1.1%-39.4%NT$751.1mn/an/an/an/a

7561

Bioray Biotech
NT$25.15-0.2%-26.0%NT$756.6mn/aPS3.9xn/a0.8%

6876

LAUNXP Biomedical
NT$26.500%n/aNT$853.0mn/an/an/an/a

6549

TaiwanJ Pharmaceuticals
NT$12.00-4.8%-60.7%NT$901.5mn/aPS39.6xn/an/a

6662

BioLASCO Taiwan
NT$35.802.4%19.3%NT$916.9mn/aPE18.4xn/a4.6%

6709

Advagene Biopharma
NT$18.407.6%-39.9%NT$982.2mn/aPB7xn/an/a

7595

Pharmigene
NT$19.60-1.3%-14.8%NT$989.1mn/aPS7.5xn/an/a

6610

TWi Biotechnology
NT$11.40-1.7%-42.3%NT$999.2mn/aPB6xn/an/a

7607

DuoGenic StemCells
NT$33.001.5%n/aNT$1.0bn/an/an/an/a

6483

Original BioMedicals
NT$15.85-6.8%n/aNT$1.0bn/aPS24162xn/an/a

6935

Prince Pharmaceutical
NT$29.50-4.5%-35.4%NT$1.1bn/aPE69.7xn/a0.5%

6814

Lukas Biomedical
NT$29.00-3.8%-22.0%NT$1.1bn/aPS4.6xn/an/a

4131

NeoCore Technology
NT$30.90-0.3%9.2%NT$1.2bn/aPS18.9xn/an/a

6652

Eusol BiotechLtd
NT$9.093.5%-26.7%NT$1.2bn/aPB3.1xn/an/a

6810

Bio Preventive Medicine
NT$37.000%-3.4%NT$1.3bn/an/an/an/a

4160

Genetics Generation Advancement
NT$50.3020.5%54.6%NT$1.3bn/aPE44.7xn/a1.0%

4117

General Biologicals
NT$21.502.4%-20.7%NT$1.3bn/aPS4.6xn/an/a

4186

Taiwan Advance Bio-Pharmaceutical
NT$14.80-1.3%-24.7%NT$1.3bn/aPS4.2xn/an/a

4195

Genomics BioSci & Tech.Ltd
NT$18.653.3%-5.8%NT$1.4bn/aPS3.4xn/a0%
Page 1 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.